What Researchers Did
Researchers applied hyperbaric oxygen therapy (HBO2) to patients experiencing delayed neuropsychiatric syndrome (DNS) after carbon monoxide poisoning and evaluated its effectiveness.
What They Found
All patients experienced significant improvement in DNS symptoms after hyperbaric oxygen therapy. While white matter changes persisted on brain MRI, other neuropsychiatric tests like EEG, MMSE, ERP, and brain SPECT showed nearly normal results post-treatment.
What This Means for Canadian Patients
Hyperbaric oxygen therapy may offer a potential treatment option for Canadian patients suffering from delayed neuropsychiatric syndrome following carbon monoxide poisoning. This could lead to improved mental and motor function, enhancing recovery and quality of life for those affected.
Canadian Relevance
This study has no direct Canadian connection.
Study Limitations
The study's main limitation is the lack of a large randomized trial to definitively establish the efficacy of hyperbaric oxygen therapy.